-+ 0.00%
-+ 0.00%
-+ 0.00%

Belite Bio Q2 Adj. EPS $(0.54) Beats $(0.79) Estimate

Benzinga·08/13/2026 07:08:18
Listen to the news
Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.79) by 31.65 percent. This is a 8 percent decrease over losses of $(0.50) per share from the same period last year.